Moderna, Inc. Profile Avatar - Palmy Investing

Moderna, Inc.

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the Uni…
Biotechnology
US, Cambridge [HQ]

Filings / Resources

Link Index · Filing Reader · 10K/10Q
Loading may take some time.
SEC
2024-03-31 2023-12-31 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31
Transcripts

Gather insights into the latest earnings call through our transcripts.

Other Docs/Resources
Transcripts Investor Relations EDGAR MRNA's Industry Healthcare Analysis Biotechnology Analysis US Analysis Cambridge Analysis
End of MRNA's Analysis
CIK: 1682852 CUSIP: 60770K107 ISIN: US60770K1079 LEI: - UEI: -
Secondary Listings
XETRA:0QF.F